For columnist Desiree Lama, MS Awareness Month is an opportunity for people living with MS to speak their truth about their ...
Every few years, American politics rediscovers chronic disease. Leaders point to rising rates of diabetes, heart disease and ...
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in ...
Here are the differences between biological and chronological age, and how this growing scientific concept is shaping debates ...
A Cambridge endometriosis advocate’s petition calling for change in how the disease is treated and recognized in Canada is ...
A new wave of immuno-therapies is reshaping the fight against cancer, turning the body’s own immune system into a powerful ...
As you have seen, it has been a very active time at Eton. During the call, we will review fourth quarter results, provide additional color on the Hemangiol acquisition, and an update on our recent FDA ...
Under new regulations, employees who are injured or fall ill because of working conditions will receive stronger support ...
Here comes Big Brother. Senate Bill 2461 would ban some common pre-implantation genetic tests used in IVF care to screen for hundreds of hereditary, genetic disorders, such as Tay-Sachs disease, ...
Beijing Financial Court recently upheld a ruling in favor of a woman whose insurance claim had been denied over alleged nondisclosure of her family's cancer history, reinforcing the need for insurers ...
Global data from over 12,000 consumers signals the future of modern aesthetics will be multimodal treatment plans and holistic, natural results ...
Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results